Four Men Indicted in Mojo Nights Misbranded Dietary Supplement Case

Mojo_Nights

Over the last year the FDA has sent our numerous warnings about the dietary supplement “Mojo Nights” for containing unacknowledged prescription medication. Now four people who marketed and sold Mojo Nights have been indicted for distribution of misbranded drugs.

The FDA first warned the public about the Mojo Nights dietary supplements in May 2012, advising consumers to “stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a health care professional as soon as possible.”

Identified on the label and in the ingredients list as a natural dietary supplement, Mojo Nights was marketed and sold online and in stores as an herbal sexual enhancer. The FDA issued a warning on Mojo Nights because laboratory tests by the FDA found the undeclared ingredients tadalafil, sildenafil, sulfoaildenafil, sulfosildenafil, and hydroxythiohomosildenafil. All are either prescription ingredients or analogues that are used in ED treatments, according to the FDA warning. The FDA warns, “These undeclared ingredients may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels.” Additionally, they warn, men with high blood pressure, high cholesterol, heart disease and diabetes may have dangerous interactions between these drugs and medications that contain nitrates.

Four months later, the FDA posted the first of two product recalls for Mojo Nights and Mojo Nights For Her in September, citing their undeclared active ingredients in the form of prescription ED medications. In December of 2012, the second product recall was conducted, citing all lots of Mojo Nights, Blue Diamond, Casanova and Libigrow as containing undeclared prescription drugs.

This March the Department of Justice announced that 4 men had been charged in a conspiracy to distribute misbranded drugs for their role in the sale of Mojo Nights. Almuntasser “Alex” Hbaiu, Gil Conrad Dizon, and Christopher Mouzon of Los Angeles, were all indicted in various criminal charges related to introducing misbranded drugs into interstate commerce, as was Ahed Hbaiu, of Etters, Pennsylvania.

Ahed Hbaiu was also charged with criminal fraud for illegally obtaining credit cards in his mother’s name and in the name of a person serving a life sentence in jail, reports the DOJ. The York Dispatch reports that he has left the country and is currently on the run from authorities.

Gil Conrad Dizon is currently reported to be in the Philippines. Warrants have been issued for both men. The indictments have been sealed by the Grand Jury in Pennsylvania, pending the arrest of the remaining suspects, according to the DOJ.

By S. Imber

|


Want to get a summary of global counterfeit drug news emailed to you every week? Sign up for our email list!

 Email:


2014 Interchange Save the Date

The 5 Secrets Canadian Web Pharmacies Don't Want You To Know
Learn the secrets!


Report Counterfeit and Black Market Medicines

Track & Trace legislation
President Obama signed into law, on November 27, 2013, legislation to enhance the safety of the drug supply chain, which has seen a number of incidents in recent years threaten American patients.   Learn more>>


Get Breaking News

 

Youtube  Follow Us on Twitter Like us on Facebook Flickr Delicious Stumble Upon Tumblr

Drug Safety Alert

FDA warns consumers about potential health risks from using Thorne Research’s Captomer products (June 12)

counterfeit drug alerts to tweet Tweet this alert!

Counterfeit Drug Incident Encyclopedia

counterfeit drug incident encyclopedia banner